Junshi Expands Toripalimab to Stage II-III NSCLC
SHANGHAI, China, July 21, 2026 Junshi Biosciences has announced that the National Medical Products Administration (NMPA) has accepted a...
AI drug discovery
Advertisement
Healx Doses First Patient in HLX-4310 Phase 1/2 Trial
CAMBRIDGE, UK, July 22, 2026 Healx, an AI-powered clinical-stage biotechnology company, has announced that the first patient has been...
Bristol Myers Squibb Expands AI Collaboration with NVIDIA
PRINCETON, N.J., July 20, 2026 Bristol Myers Squibb (BMS) announced a major expansion of its strategic collaboration with NVIDIA...
Aqemia Broadens AI Drug Discovery Research with Sanofi
PARIS & LONDON, July 17, 2026 Aqemia, the biotechnology company pioneering physics-based generative artificial intelligence (AI) for drug discovery,...
Galmed Accelerates Heart Failure Innovation with Aramchol
RAMAT-GAN, Israel, July 16, 2026 Galmed Pharmaceuticals Ltd. has announced the breakthrough development of a novel lipid nanoparticle (LNP)...
Advertisements
Levee Medical Completes ARID II Trial Enrollment for Voro
DURHAM, N.C., July 14, 2026 Levee Medical has reached a significant clinical development milestone with the successful completion of...
Chai Discovery Secures $400M to Transform AI Drug Discovery
SAN FRANCISCO, July 17, 2026 Chai Discovery has announced the successful completion of a $400 million Series C financing...
Senhwa Biosciences Secures NT$500M GEM Investment Deal
TAIPEI, Taiwan & SAN DIEGO, Calif., July 14, 2026 Senhwa Biosciences, Inc. has entered into a significant financing agreement...
Insilico Medicine Partners Bora for AI Drug Innovation
HONG KONG & TAIPEI, Taiwan, July 14, 2026 Insilico Medicine and Bora Pharmaceuticals Co., Ltd. have announced a landmark...
Hummingbird Bioscience Wins 2026 APAC AI Trailblazer Award
SINGAPORE, July 14, 2026 Hummingbird Bioscience has been recognized with the prestigious Asia Pacific Trailblazer Award at the 2026...
Advertisement
